HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement Polish Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gorter, R. W. Articles by Sluis, W. v. d. Search for Related Content PubMed PubMed Citation Articles by Gorter, R. W. Articles by Sluis, W. v. d.

Medical use of cannabis in the Netherlands

From the International Institute for Oncological and Immunological Research (Drs. Gorter and Cobian, M. Butorac), Cologne, and University Witten/Herdecke Medical School (Dr. Gorter), Germany; University of California San Francisco Medical School (Dr. Gorter) and Institute of Holistic Studies (Dr. Gorter), San Francisco State University, CA; School of Pharmacy (Dr. Gorter), University of the Western Cape, Cape Town, South Africa; and School of Pharmacy (Dr. van der Sluis), University of Utrecht, the Netherlands.

Address correspondence and reprint requests to Dr. R.W. Gorter, International Institute for Oncological and Immunological Research, Hohenstaufenring 30-32, 50674 Cologne, Germany; e-mail: robert.gorter{at}cancer-society.org

The authors investigated the indications for cannabis prescription in the Netherlands and assessed its efficacy and side effects. A majority (64.1%) of patients reported a good or excellent effect on their symptoms. Of these patients, approximately 44% used cannabis for 5 months. Indications were neurologic disorders, pain, musculoskeletal disorders, and cancer anorexia/cachexia. Inhaled cannabis was perceived as more effective than oral administration. Reported side effects were generally mild.

This article has been cited by other articles:

				I. B. Corless, T. Lindgren, W. Holzemer, L. Robinson, S. Moezzi, K. Kirksey, C. Coleman, Y.-F. Tsai, L. Sanzero Eller, M. J. Hamilton, et al. Marijuana Effectiveness as an HIV Self-Care Strategy Clin Nurs Res, May 1, 2009; 18(2): 172 - 193. [Abstract] [PDF]

				H. R. Ross, I. Napier, and M. Connor Inhibition of Recombinant Human T-type Calcium Channels by {Delta}9-Tetrahydrocannabinol and Cannabidiol J. Biol. Chem., June 6, 2008; 283(23): 16124 - 16134. [Abstract] [Full Text] [PDF]

				M S Chong, K Wolff, K Wise, C Tanton, A Winstock, and E Silber Cannabis use in patients with multiple sclerosis Multiple Sclerosis, September 1, 2006; 12(5): 646 - 651. [Abstract] [PDF]